DR. ANDREW SCOTT FLUM M.D. NPI 1861712671

NPI Details

DR. Andrew Scott Flum, M.D. is an urology in Overland Park, KS with 16 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. Andrew Scott Flum, M.D. NPI is 1861712671. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF MICHIGAN HOMEOPATHIC MEDICAL SCHOOL
Graduation Year:2010

The provider's business location address is:

10701 NALL AVE STE 100
OVERLAND PARK, KS
ZIP 66211-244
Phone: (913) 338-5585
Fax: (913) 338-3228

The NPI 1861712671 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Bcg live intravesical instillation, 1 mg (HCPCS:J9030)
• Injection, propofol, 10 mg (HCPCS:J2704)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Urinalysis, manual test (HCPCS:81002)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Blood creatinine level (HCPCS:82565)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Biopsy of prostate gland (HCPCS:55700)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• Injection, ciprofloxacin for intravenous infusion, 200 mg (HCPCS:J0744)
• Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings (HCPCS:51784)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• Insertion of device into abdomen with pressure and urine flow rate study (HCPCS:51797)
• Complex measurement of pressure of urine flow in bladder with voiding pressure studies (HCPCS:51728)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Testosterone (hormone) level, total (HCPCS:84403)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Ct scan of abdomen before and after contrast (HCPCS:74170)
• Complex measurement of pressure of urine flow in bladder with urethra pressure studies (HCPCS:51727)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 6/3/2010 and was last updated on 1/18/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.